Privia Health Group, Inc. PRVA
- Employees
- 1,226
- Headquarters
- Arlington, VA
- Next results
- around Feb 25, 2027
PRVA among Health care peers
Six ratios from the latest 10-K. Each corner is the share of 154 peers the company is above, not a score.
What changed
6 new risk paragraphs. 10-K filed Feb 27, 2026 against Feb 27, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
10 checks on the latest 10-K. Checks, not verdicts.
0facts worth reading about all 10 checks found nothing to note
-
Receivables +26.8% ($316.2M to $400.9M) vs revenue +22.3% ($1.7B to $2.1B), +4.5 pts apart
-
Cash from operations $163.4M vs net income $22.9M (FY ending Dec 31, 2025)
-
Same auditor in both 10-Ks: PricewaterhouseCoopers LLP
7 more checks with nothing to note
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
The same matters as last year: Valuation of Fee for Service Patient Care Accounts Receivable; Valuation of Medicare Shared Savings Program Revenue
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
6 paragraphs in Risk Factors that were not in the 10-K filed Feb 27, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Feb 27, 2025 10-K, ITEM 1A
We may encounter difficulty acquiring entities or assets, face challenges integrating the operations of acquired businesses or realizing expected results or become liable for unknown or contingent liabilities as a result of acquisitions. A component of our business strategy is making acquisitions and entering into joint ventures with…
New risk paragraphs, against peers
Latest 10-K of each, Health care companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $1.4B | $1.7B | $1.7B | $2.1B |
| Net income | −$8.6M | $23.1M | $14.4M | $22.9M |
| Operating cash flow | $47.2M | $80.8M | $109.3M | $163.4M |
| Free cash flow | $47.1M | $80.7M |
Revenue, FY2019 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$2.1B ▲ 22.3% in FY2025$22.9M ▲ 59.3% in FY2025
Recent filings
4 filings in the last 30 days · SEC EDGAR
-
Planned saleNov 5, 2026Parth Mehrotra (Chief Executive Officer and a member of the Board) adopted a 10b5-1 trading plan reported in the 10-Q, up to 1,229,423 shares, runs to Aug 4, 2028
-
Planned saleNov 5, 2026David Mountcastle (Chief Financial Officer) adopted a 10b5-1 trading plan reported in the 10-Q, up to 181,230 shares, runs to Nov 30, 2027
-
8-KNov 5, 2026Quarterly results 8-K item 2.02
-
10-QNov 5, 2026Quarterly report (10-Q) period ended Sep 30, 2026
About the company
Privia Health Group, Inc., Arlington, VA · from the 10-K filed Feb 27, 2026
Privia Health Group, Inc. (“Privia Health”, “we”, “our”, or the “Company”) is a technology-driven, national physician-enablement company that collaborates with physician practices, health plans, and health systems to achieve the quadruple aim of better outcomes, lower costs, improved patient experience, and happier and more engaged providers.
- Headquarters
- Arlington, VA
- Country
- United States
- Reports in
- USD
- Listed on
- Nasdaq
- Fiscal year ends
- December 31
- Last results
- Nov 5, 2026
- Incorporated in
- DE
Employees, at the top of the page: ", we had 1,226 employees in 43 states and the District of Columbia" (10-K). Address and exchange: SEC's company file.
Email alerts
Sources
The 10-K filed Feb 27, 2026 (open at SEC), compared with the 10-K filed Feb 27, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/PRVA/export.csv") into a cell.